Literature DB >> 18720182

Abbreviated neuropsychological assessment in schizophrenia: prediction of different aspects of outcome.

Philip D Harvey1, Richard S E Keefe, Thomas L Patterson, Robert K Heaton, Christopher R Bowie.   

Abstract

The aim of this study was to identify the best subset of neuropsychological tests for prediction of several different aspects of functioning in a large (n = 236) sample of older people with schizophrenia. While the validity of abbreviated assessment methods has been examined before, there has never been a comparative study of the prediction of different elements of cognitive impairment, real-world outcomes, and performance-based measures of functional capacity. Scores on 10 different tests from a neuropsychological assessment battery were used to predict global neuropsychological (NP) performance (indexed with averaged scores or calculated general deficit scores), performance-based indices of everyday-living skills and social competence, and case-manager ratings of real-world functioning. Forward entry stepwise regression analyses were used to identify the best predictors for each of the outcomes measures. Then, the analyses were adjusted for estimated premorbid IQ, which reduced the magnitude, but not the structure, of the correlations. Substantial amounts (over 70%) of the variance in overall NP performance were accounted for by a limited number of NP tests. Considerable variance in measures of functional capacity was also accounted for by a limited number of tests. Different tests constituted the best predictor set for each outcome measure. A substantial proportion of the variance in several different NP and functional outcomes can be accounted for by a small number of NP tests that can be completed in a few minutes, although there is considerable unexplained variance. However, the abbreviated assessments that best predict different outcomes vary across outcomes. Future studies should determine whether responses to pharmacological and remediation treatments can be captured with brief assessments as well.

Entities:  

Mesh:

Year:  2009        PMID: 18720182      PMCID: PMC2668735          DOI: 10.1080/13803390802251386

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  44 in total

1.  Initial validation of a screening battery for the detection of HIV-associated cognitive impairment.

Authors:  Catherine L Carey; Steven Paul Woods; Julie D Rippeth; Raul Gonzalez; David J Moore; Thomas D Marcotte; Igor Grant; Robert K Heaton
Journal:  Clin Neuropsychol       Date:  2004-05       Impact factor: 3.535

2.  The positive and negative syndrome scale (PANSS) for schizophrenia.

Authors:  S R Kay; A Fiszbein; L A Opler
Journal:  Schizophr Bull       Date:  1987       Impact factor: 9.306

3.  The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology.

Authors:  N C Andreasen; M Flaum; S Arndt
Journal:  Arch Gen Psychiatry       Date:  1992-08

4.  Neuropsychological deficits in schizophrenics. Relationship to age, chronicity, and dementia.

Authors:  R Heaton; J S Paulsen; L A McAdams; J Kuck; S Zisook; D Braff; J Harris; D V Jeste
Journal:  Arch Gen Psychiatry       Date:  1994-06

5.  The relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to functional capacity and real-world functional outcome.

Authors:  Richard S E Keefe; Margaret Poe; Trina M Walker; Philip D Harvey
Journal:  J Clin Exp Neuropsychol       Date:  2006-02       Impact factor: 2.475

6.  Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites.

Authors:  P D Harvey; E Howanitz; M Parrella; L White; M Davidson; R C Mohs; J Hoblyn; K L Davis
Journal:  Am J Psychiatry       Date:  1998-08       Impact factor: 18.112

7.  Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures.

Authors:  Christopher R Bowie; Winnie W Leung; Abraham Reichenberg; Margaret M McClure; Thomas L Patterson; Robert K Heaton; Philip D Harvey
Journal:  Biol Psychiatry       Date:  2007-07-27       Impact factor: 13.382

8.  Barriers to employment for people with schizophrenia.

Authors:  Robert Rosenheck; Douglas Leslie; Richard Keefe; Joseph McEvoy; Marvin Swartz; Diana Perkins; Scott Stroup; John K Hsiao; Jeffrey Lieberman
Journal:  Am J Psychiatry       Date:  2006-03       Impact factor: 18.112

9.  The continuous performance test, identical pairs version: II. Contrasting attentional profiles in schizophrenic and depressed patients.

Authors:  B A Cornblatt; M F Lenzenweger; L Erlenmeyer-Kimling
Journal:  Psychiatry Res       Date:  1989-07       Impact factor: 3.222

Review 10.  What are the functional consequences of neurocognitive deficits in schizophrenia?

Authors:  M F Green
Journal:  Am J Psychiatry       Date:  1996-03       Impact factor: 18.112

View more
  23 in total

1.  Processing speed and executive functions predict real-world everyday living skills in adolescents with early-onset schizophrenia.

Authors:  O Puig; R Penadés; I Baeza; V Sánchez-Gistau; E De la Serna; L Fonrodona; S Andrés-Perpiñá; M Bernardo; J Castro-Fornieles
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-02-22       Impact factor: 4.785

2.  Exploratory analysis of normative performance on the UCSD Performance-Based Skills Assessment-Brief.

Authors:  Lea Vella; Thomas L Patterson; Philip D Harvey; Margaret McNamara McClure; Brent T Mausbach; Michael J Taylor; Elizabeth W Twamley
Journal:  Psychiatry Res       Date:  2017-06-12       Impact factor: 3.222

3.  Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers.

Authors:  Brett A Clementz; John A Sweeney; Jordan P Hamm; Elena I Ivleva; Lauren E Ethridge; Godfrey D Pearlson; Matcheri S Keshavan; Carol A Tamminga
Journal:  Am J Psychiatry       Date:  2015-12-07       Impact factor: 18.112

4.  Cannabis use disorders in schizophrenia: effects on cognition and symptoms.

Authors:  Pamela DeRosse; Alyson Kaplan; Katherine E Burdick; Todd Lencz; Anil K Malhotra
Journal:  Schizophr Res       Date:  2010-05-18       Impact factor: 4.939

5.  Virtual reality assessment of functional capacity in the early course of schizophrenia: Associations with cognitive performance and daily functioning.

Authors:  Joseph Ventura; Tamara Welikson; Arielle Ered; Kenneth L Subotnik; Richard S E Keefe; Gerhard S Hellemann; Keith H Nuechterlein
Journal:  Early Interv Psychiatry       Date:  2019-06-10       Impact factor: 2.732

Review 6.  Effect of second-generation antipsychotics on cognition: current issues and future challenges.

Authors:  S Kristian Hill; Jeffrey R Bishop; Donna Palumbo; John A Sweeney
Journal:  Expert Rev Neurother       Date:  2010-01       Impact factor: 4.618

7.  Cognitive impairments in psychotic disorders: common mechanisms and measurement.

Authors:  Deanna M Barch; Julia M Sheffield
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

8.  Development of abbreviated eight-item form of the Penn Verbal Reasoning Test.

Authors:  Warren B Bilker; Michael R Wierzbicki; Colleen M Brensinger; Raquel E Gur; Ruben C Gur
Journal:  Assessment       Date:  2014-02-26

9.  Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study.

Authors:  S Kristian Hill; James L Reilly; Richard S E Keefe; James M Gold; Jeffrey R Bishop; Elliot S Gershon; Carol A Tamminga; Godfrey D Pearlson; Matcheri S Keshavan; John A Sweeney
Journal:  Am J Psychiatry       Date:  2013-11       Impact factor: 18.112

10.  Validation of a Computerized test of Functional Capacity.

Authors:  Richard S E Keefe; Vicki G Davis; Alexandra S Atkins; Adam Vaughan; Tom Patterson; Meera Narasimhan; Philip D Harvey
Journal:  Schizophr Res       Date:  2016-04-16       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.